Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

18F-EF5

PROCEDURE

Pretreatment PET/CT-scan (performed two times)

Trial Locations (1)

FI-20521

Turku University Hospital, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT01774760 - Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer | Biotech Hunter | Biotech Hunter